• VANLALFAKZELI Department of Pharmacy Practice, S J M College of Pharmacy, Chitradurga 577502, Karnataka, India
  • VARADHA PAYANGOTT Department of Pharmacy Practice, S J M College of Pharmacy, Chitradurga 577502, Karnataka, India
  • ABUBAKER SIDDIQ Department of Pharmacology, S J M College of Pharmacy, Chitradurga 577502, Karnataka, India



COVID-19 (Coronavirus disease 2019), Disease, Vaccine, Effects


Objective: The main objective of this study was to assess the QOL (quality of life) and effects on the recovered and vaccinated COVID-19study population.

Methods: A cross-sectional observational study was carried out for six months among residential areas and selected individuals regardless of country. Demographic details and responses were collected through phone calls and also using google form questionnaires.

Results: A total of 264 subjects were enrolled in this study. In the selected study of recovered patients, it was found that females (mean score 21.9) experience high effects compared to males (mean score 39.6) since a low mean score means higher post-effects. In the evaluation of post-vaccination effects of the selected study population, it was found that males and females experience different levels of post-vaccination effects in which females(mean score 19.5) experience high effects comparatively to males (mean score 21.9). The result of the quality of life for both recovered patients and the vaccinated population infers that the younger age group was found to experience a high quality of life than the older age group who were>65 y of age.

Conclusion: The study concludes that the elderly population of>65 y of age and females based on gender were likely to suffer from post-COVID-19 effects and post-vaccination effects. It can also be concluded that the younger age group has a healthy standard of living compared to the age group>65 y.


Download data is not yet available.


Welte T, Ambrose LJ, Sibbring GC, Sheikh S, Müllerova H, Sabir I. Current evidence for COVID-19 therapies: a systematic literature review. Eur Respir Rev. 2021 Feb 10;30(159):200384. doi: 10.1183/16000617.0384-2020, PMID 33731328.

Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. J Heart Lung Transplant. 2020 March 20;39(5):405-7. doi: 10.1016/j.healun.2020.03.012, PMID 32362390.

Mahmood Alabdali A, Chinnappan S, ABD Razik B, RM Khalivulla S, HR Samein L. Impact of COVID-19 on multiple organ failure: a review. International Journal of Applied Pharmaceutics. 2021 June 19;13(5):54-9.

Ahmad S. A review of COVID-19 (Coronavirus disease-2019) Diagnosis, treatments and prevention. Eurasian J Med Oncol. 2020 April 15. doi: 10.14744/ejmo.2020.90853.

Lima CMAO. Information about the new coronavirus disease (COVID-19). Radiol Bras. 2020;53(2):V-VI. doi: 10.1590/0100-3984.2020.53.2e1, PMID 32336833.

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA. BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021 April 15;384(15):1412-23. doi: 10.1056/NEJMoa2101765, PMID 33626250.

Niharika D, Niharika B, Aishwarya T, Nikitha A, Butool R, Ibrahim M. Coronavirus-a virus in learning. Int J Curr Pharm Sci. 2020 May 25;12(4):7-10. doi: 10.22159/ijcpr.2020v12i4.39078.

Sah R, Shrestha S, Mehta R, Sah SK, Rabaan AA, Dhama K. AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges, and solutions in Nepal. Travel Med Infect Dis. 2021 Feb 10;40:101989. doi: 10.1016/j.tmaid.2021.101989, PMID 33578045.

Kulkarni M, Patel P, Yadav N, Gupta S. Clinical profile and outcomes of COVID-19 patients: a retrospective observational study from tertiary care centre in North India. SK T, Ravishekar NH, SK C. Asian J Pharm Clin Res. 2022;15(5):128-31.

SP, Sundararajan M, AM. Insights into corona/coronavirus disease 2019 pandemic–opinion versus evidence. Asian J Pharm Clin Res. 2021;14(7):13-5.

Riad A, Pokorna A, Attia S, Klugarova J, Koscik M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021 April 1;10(7):1428. doi: 10.3390/jcm10071428, PMID 33916020.

House CN, Palissery S, Sebastian H. Coronaviruses: a review on SARS, MERS, and COVID-19. Microbiol Insights. 2021 March 19;14:117863612110024.

Dhar Chowdhury S, Oommen AM. Epidemiology of COVID-19. J Dig Endosc. 2020 March;11(1):03-7. doi: 10.1055/s-0040-1712187.

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS. Post-acute COVID-19 syndrome. Nat Med. 2021 March 22;27(4):601-15. doi: 10.1038/s41591-021-01283-z, PMID 33753937.

Arab Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect. 2020 Oct;11(5):296-302. doi: 10.24171/j.phrp.2020.11.5.05, PMID 33117634.

Vahia IV, Jeste DV, Reynolds CF. Older adults and the mental health effects of COVID-19. JAMA. 2020;324(22):2253-4. doi: 10.1001/jama.2020.21753, PMID 33216114.

Martins Van Jaarsveld G. The effects of COVID-19 among the elderly population: A case for closing the digital divide. Front Psychiatry. 2020;11:577427. doi: 10.3389/fpsyt.2020.577427, PMID 33304283.

Walle Hansen MM, Ranhoff AH, Mellingsæter M, Wang Hansen MS, Myrstad M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021 March 22;21(1):199. doi: 10.1186/s12877-021-02140-x, PMID 33752614.

McCartney PR. Sex-based vaccine response in the context of COVID-19. J Obstet Gynecol Neonatal Nurs. 2020;49(5):405-8. doi: 10.1016/j.jogn.2020.08.001, PMID 32800743.

Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F. Persistent fatigue following SARS-CoV-2 infection is common and independent of the severity of initial infection. PLOS ONE. 2020 Nov 9;15(11):e0240784. doi: 10.1371/ journal.pone.0240784, PMID 33166287.

Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021 July;21(7):939-49. doi: 10.1016/S1473-3099(21)00224-3, PMID 33930320.



How to Cite

VANLALFAKZELI, V. PAYANGOTT, and A. SIDDIQ. “ASSESSMENT OF QUALITY OF LIFE AND EFFECTS IN RECOVERED AND VACCINATED COVID-19 POPULATION: A CROSS-SECTIONAL OBSERVATIONAL STUDY”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 7, July 2022, pp. 1-5, doi:10.22159/ijpps.2022v14i7.44882.



Original Article(s)